The biotech industry has been a robust roller-coaster over the last half decade. The State Street SPDR S&P Biotech ETF (NYSE: ...
What if the biggest winners in biotech weren’t the ones promising miracle cures, but the ones quietly supplying the picks and ...
Biotech held steady in early 2026 as M&A buyouts and rotation from the Magnificent Seven lifted IBB relative strength—read ...
The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force ...
Anthropic has acquired Coefficient Bio, a stealth biotech startup with fewer than 10 people, for $400 million in stock. The ...
While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...
Mantis takes disparate sources of data to make synthetic datasets that can be used to build so-called "digital twins" of the ...
Ambrosia Biosciences is aiming to move the market beyond peptide-based obesity treatments and initiate a trial for its oral ...
Morning Overview on MSN
Mantis Biotech builds human digital twins to tackle medical data gaps
Mantis Biotechnology Corp, a San Francisco-based startup, is building simulated human bodies to generate the synthetic ...
Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only ...
Discover the Latest in Research Peptides at Biotech Labz Supply Sebastopol, United States - January 3, 2026 / Biotech ...
PSC Biotech partners with Blue Ocean Robotics to distribute the UVD Robot Pharma delivering autonomous UV C disinfection for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results